FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Arch Virol / Equine gammaherpesvirus 2 (EHV2) is latent in B lymphocytes.
Archives of virology1996; 141(3-4); 495-504; doi: 10.1007/BF01718313

Equine gammaherpesvirus 2 (EHV2) is latent in B lymphocytes.

Abstract: Peripheral blood leukocytes were collected from 5 Thoroughbred horses and examined for the presence of EHV2 in sub-populations of mononuclear cells. Peripheral blood mononuclear cells were separated on Percoll gradients and then enriched for plastic adherent cells (predominantly monocytes), surface immunoglobulin positive (sIg+) B lymphocytes and T lymphocytes, using panning techniques. The purity of each cell population was assessed by fluorescence activated cell scanning. In an infectious centre assay, each cell population was inoculated onto equine foetal kidney monolayer cell cultures which are fully permissive for the replication of EHV2. Only enrichment for sIg+ B lymphocytes resulted in a marked increase in the number of infectious centres, indicating that EHV2 is present in B lymphocytes. Freeze-thawing of sIg+ B lymphocytes, prior to inoculation onto EFK monolayer cell cultures, resulted in the complete abrogation of infectious centre formation, confirming that EHV2 is latent in B lymphocytes i.e., infectious free virus was not present in the cells. The number of EHV2 infected B lymphocytes varied considerably between horses from 4 to 780 per 10(6) cells. Evidence was also obtained that direct cell to cell contact between the epithelial cells and sIg+ B lymphocytes was necessary for the production of infectious centres. The data indicate that EHV2, like other members of the Gammaherpesvirinae, is latent within B lymphocytes.
Get Full Text
Publication Date: 1996-01-01 PubMed ID: 8645091DOI: 10.1007/BF01718313Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research focuses on equine gammaherpesvirus 2 (EHV2), finding that it is dormant within B lymphocytes in Thoroughbred horses. It also presents evidence that direct cell to cell contact between epithelial cells and sIg+ B lymphocytes is necessary for infection.

Methodology

  • Peripheral blood leukocytes were gathered from five Thoroughbred horses. These white blood cells were then examined for the presence of EHV2 in their different mononuclear cell populations.
  • By using various techniques such as panning and Percoll gradients separation, the peripheral blood mononuclear cells were divided into three groups: plastic adherent cells (which are mainly monocytes), sIg+ B lymphocytes, and T lymphocytes.
  • The researchers then determined each cell group’s purity through a method known as fluorescence-activated cell scanning.

Infectious Centre Assay

  • The infectious centre assay involved inoculating each cell population onto equine foetal kidney monolayer cell cultures. These culture environments allow EHV2 to replicate.
  • Only when the sIg+ B lymphocytes were enriched, did they observe a significant increase in the number of infectious centres. This indicated that EHV2 is present in B lymphocytes.
  • When the sIg+ B lymphocytes were subjected to freeze-thawing before being inoculated onto the EFK monolayer cell cultures, there was no generation of infectious centres. This confirmed that EHV2 is latent (or inactive) in B lymphocytes. This means that they did not carry active, infectious free virus.

Findings and Conclusion

  • The number of EHV2 infected B lymphocytes varied widely among horses. It was found to range from 4 to 780 per million cells.
  • The study also found evidence suggesting that for the production of infectious centres, there is a need for direct cell-to-cell contact between the epithelial cells and sIg+ B lymphocytes.
  • All these findings led to the conclusion that EHV2, similar to other Gammaherpesvirinae members, is latent within B lymphocytes.

Cite This Article

APA
Drummer HE, Reubel GH, Studdert MJ. (1996). Equine gammaherpesvirus 2 (EHV2) is latent in B lymphocytes. Arch Virol, 141(3-4), 495-504. https://doi.org/10.1007/BF01718313

Publication

Archives of virology
ISSN: 0304-8608
NlmUniqueID: 7506870
Country: Austria
Language: English
Volume: 141
Issue: 3-4
Pages: 495-504

Researcher Affiliations

Drummer, H E
  • Centre for Equine Virology, School of Veterinary Science, University of Melbourne, Parkville, Victoria, Australia.
Reubel, G H
    Studdert, M J

      MeSH Terms

      • Animals
      • B-Lymphocytes / immunology
      • B-Lymphocytes / virology
      • CD3 Complex
      • Cells, Cultured
      • DNA, Viral / analysis
      • Female
      • Gammaherpesvirinae / genetics
      • Gammaherpesvirinae / isolation & purification
      • Herpesviridae Infections / veterinary
      • Herpesviridae Infections / virology
      • Horse Diseases / virology
      • Horses
      • Receptors, Antigen, B-Cell
      • T-Lymphocytes / immunology
      • T-Lymphocytes / virology
      • Virus Latency

      References

      This article includes 27 references
      1. Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mosmann TR. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI.. Science 1990 Jun 8;248(4960):1230-4.
        pubmed: 2161559doi: 10.1126/science.2161559google scholar: lookup
      2. Telford EA, Watson MS, Aird HC, Perry J, Davison AJ. The DNA sequence of equine herpesvirus 2.. J Mol Biol 1995 Jun 9;249(3):520-8.
        pubmed: 7783207doi: 10.1006/jmbi.1995.0314google scholar: lookup
      3. Blakeslee JR Jr, Olsen RG, McAllister ES, Fassbender J, Dennis R. Evidence of respiratory tract infection induced by equine herpesvirus, type 2, in the horse.. Can J Microbiol 1975 Dec;21(12):1940-6.
        pubmed: 175904doi: 10.1139/m75-281google scholar: lookup
      4. Pálfi V, Belák S, Molnár T. Isolation of equine herpesvirus type 2 from foals, showing respiratory symptoms.. Zentralbl Veterinarmed B 1978 Mar;25(2):165-7.
        pubmed: 207057doi: 10.1111/j.1439-0450.1978.tb00737.xgoogle scholar: lookup
      5. Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.. J Exp Med 1992 Jul 1;176(1):169-76.
        pubmed: 1377222doi: 10.1084/jem.176.1.169google scholar: lookup
      6. Rode HJ, Janssen W, Rösen-Wolff A, Bugert JJ, Thein P, Becker Y, Darai G. The genome of equine herpesvirus type 2 harbors an interleukin 10 (IL10)-like gene.. Virus Genes 1993 Feb;7(1):111-6.
        pubmed: 8385838doi: 10.1007/BF01702353google scholar: lookup
      7. Kramp WJ, Medveczky P, Mulder C, Hinze HC, Sullivan JL. Herpesvirus sylvilagus infects both B and T lymphocytes in vivo.. J Virol 1985 Oct;56(1):60-5.
        pubmed: 2993667doi: 10.1128/JVI.56.1.60-65.1985google scholar: lookup
      8. Studdert MJ. Equine herpesviruses. 4. Concurrent infection in horses with strangles and conjunctivitis.. Aust Vet J 1971 Sep;47(9):434-6.
        pubmed: 4331251doi: 10.1111/j.1751-0813.1971.tb02175.xgoogle scholar: lookup
      9. Roeder PL, Scott GR. The prevalence of equid herpes virus 2 infections.. Vet Rec 1975 May 3;96(18):404-5.
        pubmed: 167501doi: 10.1136/vr.96.18.404google scholar: lookup
      10. Mage MG, McHugh LL, Rothstein TL. Mouse lymphocytes with and without surface immunoglobulin: preparative scale separation in polystyrene tissue culture dishes coated with specifically purified anti-immunoglobulin.. J Immunol Methods 1977;15(1):47-56.
        pubmed: 15036doi: 10.1016/0022-1759(77)90016-3google scholar: lookup
      11. Jolly PD, Fu ZF, Robinson AJ. Viruses associated with respiratory disease of horses in New Zealand: an update.. N Z Vet J 1986 Apr;34(4):46-50.
        pubmed: 16031261doi: 10.1080/00480169.1986.35278google scholar: lookup
      12. Kemeny L, Pearson JE. Isolation of herpesvirus from equine leukocytes: comparison with equine rhinopneumonitis virus.. Can J Comp Med 1970 Jan;34(1):59-65.
        pubmed: 4246005
      13. Belák S, Pálfi V, Tuboly S, Bartha L. Passive immunization of foals to prevent respiratory disease caused by equine herpesvirus type 2.. Zentralbl Veterinarmed B 1980;27(9-10):826-30.
        pubmed: 6164185doi: 10.1111/j.1439-0450.1980.tb02037.xgoogle scholar: lookup
      14. Reubel GH, Crabb BS, Studdert MJ. Diagnosis of equine gammaherpesvirus 2 and 5 infections by polymerase chain reaction.. Arch Virol 1995;140(6):1049-60.
        pubmed: 7611877doi: 10.1007/BF01315414google scholar: lookup
      15. Turner AJ, Studdert MJ, Peterson JE. Equine herpes viruses. 2. Persistence of equine herpesviruses in experimentally infected horses and the experimental induction of abortion.. Aust Vet J 1970 Mar;46(3):90-8.
        pubmed: 4316594doi: 10.1111/j.1751-0813.1970.tb15928.xgoogle scholar: lookup
      16. Sunil-Chandra NP, Efstathiou S, Nash AA. Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo.. J Gen Virol 1992 Dec;73 ( Pt 12):3275-9.
        pubmed: 1469366doi: 10.1099/0022-1317-73-12-3275google scholar: lookup
      17. Welch HM, Bridges CG, Lyon AM, Griffiths L, Edington N. Latent equid herpesviruses 1 and 4: detection and distinction using the polymerase chain reaction and co-cultivation from lymphoid tissues.. J Gen Virol 1992 Feb;73 ( Pt 2):261-8.
        pubmed: 1347078doi: 10.1099/0022-1317-73-2-261google scholar: lookup
      18. Moss DJ, Misko IS, Sculley TB, Apolloni A, Khanna R, Burrows SR. Immune regulation of Epstein-Barr virus (EBV): EBV nuclear antigen as a target for EBV-specific T cell lysis.. Springer Semin Immunopathol 1991;13(2):147-56.
        pubmed: 1724100doi: 10.1007/BF00201465google scholar: lookup
      19. Wilks CR, Studdert MJ. Equine herpesviruses. 5. Epizootiology of slowly cytopathic viruses in foals.. Aust Vet J 1974 Oct;50(10):438-42.
        pubmed: 4374921doi: 10.1111/j.1751-0813.1974.tb06866.xgoogle scholar: lookup
      20. Telford EA, Studdert MJ, Agius CT, Watson MS, Aird HC, Davison AJ. Equine herpesviruses 2 and 5 are gamma-herpesviruses.. Virology 1993 Aug;195(2):492-9.
        pubmed: 8337826doi: 10.1006/viro.1993.1400google scholar: lookup
      21. Agius CT, Studdert MJ. Equine herpesviruses 2 and 5: comparisons with other members of the subfamily gammaherpesvirinae.. Adv Virus Res 1994;44:357-79.
        pubmed: 7817877doi: 10.1016/s0065-3527(08)60333-4google scholar: lookup
      22. Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, Kieff E, Rickinson AB. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.. J Exp Med 1992 Jul 1;176(1):157-68.
        pubmed: 1319456doi: 10.1084/jem.176.1.157google scholar: lookup
      23. Hsu DH, de Waal Malefyt R, Fiorentino DF, Dang MN, Vieira P, de Vries J, Spits H, Mosmann TR, Moore KW. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1.. Science 1990 Nov 9;250(4982):830-2.
        pubmed: 2173142doi: 10.1126/science.2173142google scholar: lookup
      24. Blanchard-Channell M, Moore PF, Stott JL. Characterization of monoclonal antibodies specific for equine homologues of CD3 and CD5.. Immunology 1994 Aug;82(4):548-54.
        pubmed: 7530685
      25. Klein G. Viral latency and transformation: the strategy of Epstein-Barr virus.. Cell 1989 Jul 14;58(1):5-8.
        pubmed: 2546674doi: 10.1016/0092-8674(89)90394-2google scholar: lookup
      26. Roizmann B, Desrosiers RC, Fleckenstein B, Lopez C, Minson AC, Studdert MJ. The family Herpesviridae: an update. The Herpesvirus Study Group of the International Committee on Taxonomy of Viruses.. Arch Virol 1992;123(3-4):425-49.
        pubmed: 1562239doi: 10.1007/BF01317276google scholar: lookup
      27. Vieira P, de Waal-Malefyt R, Dang MN, Johnson KE, Kastelein R, Fiorentino DF, deVries JE, Roncarolo MG, Mosmann TR, Moore KW. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI.. Proc Natl Acad Sci U S A 1991 Feb 15;88(4):1172-6.
        pubmed: 1847510doi: 10.1073/pnas.88.4.1172google scholar: lookup

      Citations

      This article has been cited 11 times.
      1. Wright BR, Jelocnik M, Casteriano A, Muir YSS, Legione AR, Vaz PK, Devlin JM, Higgins DP. Development of diagnostic and point of care assays for a gammaherpesvirus infecting koalas.. PLoS One 2023;18(6):e0286407.
        doi: 10.1371/journal.pone.0286407pubmed: 37262062google scholar: lookup
      2. Onasanya AE, El-Hage C, Diaz-Méndez A, Vaz PK, Legione AR, Browning GF, Devlin JM, Hartley CA. Whole genome sequence analysis of equid gammaherpesvirus -2 field isolates reveals high levels of genomic diversity and recombination.. BMC Genomics 2022 Aug 30;23(1):622.
        doi: 10.1186/s12864-022-08789-xpubmed: 36042397google scholar: lookup
      3. Stasiak K, Dunowska M, Rola J. Kinetics of the Equid Herpesvirus 2 and 5 Infections among Mares and Foals from Three Polish National Studs.. Viruses 2022 Mar 29;14(4).
        doi: 10.3390/v14040713pubmed: 35458443google scholar: lookup
      4. El-Hage C, Mekuria Z, Dynon K, Hartley C, McBride K, Gilkerson J. Association of Equine Herpesvirus 5 with Mild Respiratory Disease in a Survey of EHV1, -2, -4 and -5 in 407 Australian Horses.. Animals (Basel) 2021 Nov 30;11(12).
        doi: 10.3390/ani11123418pubmed: 34944194google scholar: lookup
      5. Zarski LM, Weber PSD, Lee Y, Soboll Hussey G. Transcriptomic Profiling of Equine and Viral Genes in Peripheral Blood Mononuclear Cells in Horses during Equine Herpesvirus 1 Infection.. Pathogens 2021 Jan 7;10(1).
        doi: 10.3390/pathogens10010043pubmed: 33430330google scholar: lookup
      6. Thorsteinsdóttir L, Jónsdóttir S, Stefánsdóttir SB, Andrésdóttir V, Wagner B, Marti E, Torsteinsdóttir S, Svansson V. The effect of maternal immunity on the equine gammaherpesvirus type 2 and 5 viral load and antibody response.. PLoS One 2019;14(6):e0218576.
        doi: 10.1371/journal.pone.0218576pubmed: 31226153google scholar: lookup
      7. Dall Agnol AM, Beuttemmuller EA, Pilz D, Leme RA, Saporiti V, Headley SA, Alfieri AF, Alfieri AA. Detection of Equid gammaherpesvirus 2 and 5 DNA in the upper respiratory tract of asymptomatic horses from Southern Brazil.. Braz J Microbiol 2019 Jul;50(3):875-878.
        doi: 10.1007/s42770-019-00100-7pubmed: 31187445google scholar: lookup
      8. Muscat KE, Padalino B, Hartley CA, Ficorilli N, Celi P, Knight P, Raidal S, Gilkerson JR, Muscatello G. Equine Transport and Changes in Equid Herpesvirus' Status.. Front Vet Sci 2018;5:224.
        doi: 10.3389/fvets.2018.00224pubmed: 30320126google scholar: lookup
      9. Marenzoni ML, Stefanetti V, Danzetta ML, Timoney PJ. Gammaherpesvirus infections in equids: a review.. Vet Med (Auckl) 2015;6:91-101.
        doi: 10.2147/VMRR.S39473pubmed: 30155436google scholar: lookup
      10. Wardle R, Pullman JA, Haldenby S, Ressel L, Pope M, Clegg PD, Radford A, Stewart JP, Al-Saadi M, Dyer P, Peffers MJ. Identification of Equid herpesvirus 2 in tissue-engineered equine tendon.. Wellcome Open Res 2017;2:60.
        doi: 10.12688/wellcomeopenres.12176.2pubmed: 29152595google scholar: lookup
      11. Houtsma A, Bedenice D, Pusterla N, Pugliese B, Mapes S, Hoffman AM, Paxson J, Rozanski E, Mukherjee J, Wigley M, Mazan MR. Association between inflammatory airway disease of horses and exposure to respiratory viruses: a case control study.. Multidiscip Respir Med 2015;10:33.
        doi: 10.1186/s40248-015-0030-3pubmed: 26535117google scholar: lookup
      Subscribe to our newsletter
      Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.